Sathananthan M, Farrugia LP, Miles JM, Piccinini F, Dalla Man C, Zinsmeister AR, Cobelli C, Rizza RA, Vella A. Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects. Diabetes 2013;62:2752–2756
In the article listed above, there was an error in the sentence reading, “On the other hand, exendin-(9,39), which arises from the removal of the two NH2-terminal amino acids, is a competitive antagonist of GLP-1 at the GLP-1R (5).” The sentence should read, “On the other hand, exendin-(9,39), which differs from exendin-(7,39) by the loss of two NH2-terminal amino acids, is a competitive antagonist of GLP-1 at the GLP-1R (5).”
The online version reflects these changes.
© 2013 by the American Diabetes Association.
2013
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
